EVHNYSEServices-Management ServicesFiscal year ends December 31
Evolent Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.48−0.09 (-1.97%)
Close on Oct 19, 2026
- Market cap
- $504.19M
- P/E (TTM)
- –
- Dividend yield
- –
Evolent Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Management Services companies for comparison
Valuation
| Measure | Evolent Health | Industry median |
|---|---|---|
| Market Cap | $506.51M | $74.60M |
| Enterprise Value | $1.36B | $56.72M |
| PS Ratio | 0.24 | 3.25 |
| PB Ratio | 1.32 | 3.13 |
| P/OCF Ratio | 9.33 | 15.81 |
Enterprise value
| Measure | Evolent Health | Industry median |
|---|---|---|
| EV / Sales | 0.65 | 2.79 |
Income (trailing twelve months)
| Measure | Evolent Health | Industry median |
|---|---|---|
| Revenue | $2.10B | $24.74M |
| Gross Profit | $361.64M | $19.54M |
| Operating Income | -$427.51M | -$55.64K |
| Pretax Income | -$502.14M | $45.62K |
| Net Income | -$504.99M | -$97.64K |
| EBITDA | -$315.73M | -$29.48K |
| EPS (Diluted) | -$4.57 | $0.00 |
Margins
| Measure | Evolent Health | Industry median |
|---|---|---|
| Gross Margin | 17.2% | 40.4% |
| Operating Margin | -20.4% | 0.94% |
| Pretax Margin | -23.9% | 2.64% |
| Profit Margin | -24.1% | 0.51% |
| EBITDA Margin | -15.1% | 3.48% |
Returns
| Measure | Evolent Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | -79.0% | 0.45% |
| Return on Assets (ROA) | -22.8% | -3.47% |
| Return on Invested Capital (ROIC) | -24.1% | 2.85% |
| Return on Capital Employed (ROCE) | -28.9% | 2.03% |
Growth
| Measure | Evolent Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -4.50% | 4.26% |
| Revenue Growth (3Y CAGR) | 11.5% | 2.15% |
| Revenue Growth (5Y CAGR) | 15.2% | 7.37% |
Balance sheet
| Measure | Evolent Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $115.70M | $5.43M |
| Total Debt | $966.47M | $85.44M |
| Net Cash (Debt) | -$850.76M | $17.62K |
| Net Cash Per Share | -$7.52 | $0.00 |
| Equity (Book Value) | $383.22M | $10.50M |
| Book Value Per Share | $3.39 | $0.60 |
| Tangible Book Value | -$865.64M | -$78.36K |
| Working Capital | $117.68M | $2.78M |
Financial position
| Measure | Evolent Health | Industry median |
|---|---|---|
| Current Ratio | 1.24 | 1.26 |
| Quick Ratio | 1.15 | 0.65 |
| Debt / Equity | 2.52 | 0.45 |
| Interest Coverage | -6.18 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Evolent Health | Industry median |
|---|---|---|
| Operating Cash Flow | $54.32M | $8.04K |
Efficiency
| Measure | Evolent Health | Industry median |
|---|---|---|
| Asset Turnover | 0.95 | 0.83 |
| Revenue Per Employee | $499.29K | $216.23K |
| Profits Per Employee | -$120.24K | -$3.19K |
| Employee Count | 4,200 | 123 |
Dividends and yields
| Measure | Evolent Health | Industry median |
|---|---|---|
| Earnings Yield | -99.7% | -0.97% |
Shares
| Measure | Evolent Health | Industry median |
|---|---|---|
| Shares Outstanding | 113,059,000 | 29,217,800 |
| Shares Change (YoY) | -2.38% | 0.84% |
| Float | 109,348,000 | 26,226,050 |
| Shares Held by Insiders | 3.28% | 4.85% |
| Shares Held by Institutions | 99.3% | 83.3% |
Taxes
| Measure | Evolent Health | Industry median |
|---|---|---|
| Income Tax | $2.85M | $1.36M |
Scores
| Measure | Evolent Health | Industry median |
|---|---|---|
| Altman Z-Score | -0.36 | 2.66 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -4.68 | -2.75 |
Calculated by StockData from Evolent Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.